PACRITINIB vs PANITUMUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
PACRITINIB vs PANITUMUMAB: Safety Overview
| Metric | PACRITINIB | PANITUMUMAB |
|---|---|---|
| Total FAERS Reports | 2,563 | 10,876 |
| Deaths Reported | 292 | 1,666 |
| Death Rate | 11.4% | 15.3% |
| Hospitalizations | 455 | 3,121 |
| Average Patient Age | 71.8 yrs | 63.0 yrs |
| % Female Patients | 45.1% | 36.9% |
| FDA Approval Date | Feb 28, 2022 | N/A |
| Manufacturer | Sobi, Inc. | Amgen Inc |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Prescription | Prescription |